vs

Side-by-side financial comparison of Intuitive Machines, Inc. (LUNR) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $43.3M, roughly 1.7× Intuitive Machines, Inc.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -20.8%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $-22.9M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -23.1%).

Intuitive Machines, Inc. is an American space exploration company headquartered in Houston, Texas. It was founded in 2013 by Stephen Altemus, Kam Ghaffarian, and Tim Crain, to provide commercial and government exploration of the Moon. Today the company offers lunar surface access for transportation and payload delivery, data transmission services, and infrastructure-as-a-service. Intuitive Machines holds three NASA contracts under the space agency's Commercial Lunar Payload Services (CLPS) in...

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

LUNR vs PBYI — Head-to-Head

Bigger by revenue
PBYI
PBYI
1.7× larger
PBYI
$75.5M
$43.3M
LUNR
Growing faster (revenue YoY)
PBYI
PBYI
+48.5% gap
PBYI
27.7%
-20.8%
LUNR
More free cash flow
PBYI
PBYI
$37.3M more FCF
PBYI
$14.4M
$-22.9M
LUNR
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
-23.1%
LUNR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
LUNR
LUNR
PBYI
PBYI
Revenue
$43.3M
$75.5M
Net Profit
$-39.9M
Gross Margin
69.3%
Operating Margin
-76.4%
22.7%
Net Margin
-92.1%
Revenue YoY
-20.8%
27.7%
Net Profit YoY
73.3%
EPS (diluted)
$-0.34
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LUNR
LUNR
PBYI
PBYI
Q4 25
$43.3M
$75.5M
Q3 25
$51.0M
$54.5M
Q2 25
$50.3M
$52.4M
Q1 25
$62.5M
$46.0M
Q4 24
$54.7M
$59.1M
Q3 24
$58.5M
$80.5M
Q2 24
$41.6M
$47.1M
Q1 24
$73.2M
$43.8M
Net Profit
LUNR
LUNR
PBYI
PBYI
Q4 25
$-39.9M
Q3 25
$-6.8M
$8.8M
Q2 25
$-25.2M
$5.9M
Q1 25
$-11.4M
$3.0M
Q4 24
$-149.2M
Q3 24
$-55.4M
$20.3M
Q2 24
$18.7M
$-4.5M
Q1 24
$-97.5M
$-4.8M
Gross Margin
LUNR
LUNR
PBYI
PBYI
Q4 25
69.3%
Q3 25
77.7%
Q2 25
76.5%
Q1 25
77.1%
Q4 24
76.4%
Q3 24
63.9%
Q2 24
77.4%
Q1 24
75.5%
Operating Margin
LUNR
LUNR
PBYI
PBYI
Q4 25
-76.4%
22.7%
Q3 25
-30.2%
17.6%
Q2 25
-56.9%
12.7%
Q1 25
-16.1%
8.7%
Q4 24
-24.5%
22.6%
Q3 24
-23.5%
27.4%
Q2 24
-66.0%
-4.6%
Q1 24
-3.8%
-5.3%
Net Margin
LUNR
LUNR
PBYI
PBYI
Q4 25
-92.1%
Q3 25
-13.4%
16.2%
Q2 25
-50.0%
11.2%
Q1 25
-18.2%
6.5%
Q4 24
-272.9%
Q3 24
-94.7%
25.2%
Q2 24
44.8%
-9.6%
Q1 24
-133.1%
-11.0%
EPS (diluted)
LUNR
LUNR
PBYI
PBYI
Q4 25
$-0.34
$0.26
Q3 25
$-0.06
$0.17
Q2 25
$-0.22
$0.12
Q1 25
$-0.11
$0.06
Q4 24
$-1.42
$0.40
Q3 24
$-0.83
$0.41
Q2 24
$0.30
$-0.09
Q1 24
$-2.68
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LUNR
LUNR
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$582.6M
$97.5M
Total DebtLower is stronger
$335.3M
$22.7M
Stockholders' EquityBook value
$-755.0M
$130.3M
Total Assets
$757.2M
$216.3M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LUNR
LUNR
PBYI
PBYI
Q4 25
$582.6M
$97.5M
Q3 25
$622.0M
$94.4M
Q2 25
$344.9M
$96.0M
Q1 25
$373.3M
$93.2M
Q4 24
$207.6M
$101.0M
Q3 24
$89.6M
$96.7M
Q2 24
$31.6M
$96.8M
Q1 24
$55.2M
$107.2M
Total Debt
LUNR
LUNR
PBYI
PBYI
Q4 25
$335.3M
$22.7M
Q3 25
$334.8M
$34.0M
Q2 25
$45.3M
Q1 25
$56.7M
Q4 24
$0
$68.0M
Q3 24
$79.3M
Q2 24
$90.7M
Q1 24
$102.0M
Stockholders' Equity
LUNR
LUNR
PBYI
PBYI
Q4 25
$-755.0M
$130.3M
Q3 25
$-404.2M
$115.3M
Q2 25
$-381.2M
$104.7M
Q1 25
$-136.9M
$97.1M
Q4 24
$-1.0B
$92.1M
Q3 24
$-496.8M
$71.1M
Q2 24
$-235.0M
$48.5M
Q1 24
$-493.6M
$51.0M
Total Assets
LUNR
LUNR
PBYI
PBYI
Q4 25
$757.2M
$216.3M
Q3 25
$753.5M
$202.9M
Q2 25
$475.6M
$194.9M
Q1 25
$500.0M
$196.2M
Q4 24
$355.4M
$213.3M
Q3 24
$224.8M
$220.7M
Q2 24
$140.1M
$205.0M
Q1 24
$170.8M
$214.1M
Debt / Equity
LUNR
LUNR
PBYI
PBYI
Q4 25
0.17×
Q3 25
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
0.74×
Q3 24
1.12×
Q2 24
1.87×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LUNR
LUNR
PBYI
PBYI
Operating Cash FlowLast quarter
$-7.3M
$14.4M
Free Cash FlowOCF − Capex
$-22.9M
$14.4M
FCF MarginFCF / Revenue
-53.0%
19.1%
Capex IntensityCapex / Revenue
36.1%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-56.0M
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LUNR
LUNR
PBYI
PBYI
Q4 25
$-7.3M
$14.4M
Q3 25
$-7.2M
$9.7M
Q2 25
$-19.3M
$14.1M
Q1 25
$19.4M
$3.6M
Q4 24
$-2.0M
$15.6M
Q3 24
$-17.9M
$11.0M
Q2 24
$-31.3M
$1.0M
Q1 24
$-6.4M
$11.2M
Free Cash Flow
LUNR
LUNR
PBYI
PBYI
Q4 25
$-22.9M
$14.4M
Q3 25
$-19.0M
$9.7M
Q2 25
$-27.3M
$14.1M
Q1 25
$13.3M
$3.6M
Q4 24
$-6.9M
$15.6M
Q3 24
$-19.3M
$11.0M
Q2 24
$-33.5M
$1.0M
Q1 24
$-8.0M
FCF Margin
LUNR
LUNR
PBYI
PBYI
Q4 25
-53.0%
19.1%
Q3 25
-37.2%
17.7%
Q2 25
-54.3%
26.8%
Q1 25
21.3%
7.7%
Q4 24
-12.6%
26.4%
Q3 24
-33.0%
13.7%
Q2 24
-80.4%
2.1%
Q1 24
-11.0%
Capex Intensity
LUNR
LUNR
PBYI
PBYI
Q4 25
36.1%
0.0%
Q3 25
23.2%
0.0%
Q2 25
16.0%
0.0%
Q1 25
9.8%
0.1%
Q4 24
9.0%
0.0%
Q3 24
2.4%
0.0%
Q2 24
5.3%
0.0%
Q1 24
2.2%
0.0%
Cash Conversion
LUNR
LUNR
PBYI
PBYI
Q4 25
Q3 25
1.10×
Q2 25
2.41×
Q1 25
1.21×
Q4 24
Q3 24
0.54×
Q2 24
-1.67×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons